<DOC>
	<DOCNO>NCT01254162</DOCNO>
	<brief_summary>To determine potential topically apply 0.75 % ( w/w ) MTC896 Gel reduce sebum production forehead healthy male volunteer .</brief_summary>
	<brief_title>Proof Concept Study MTC896 Gel Reduce Sebum Production Forehead Healthy Male Volunteers</brief_title>
	<detailed_description>This single-center , randomize , double-blind , placebo-controlled proof-of-concept study investigational product ( 0.75 % ( w/w ) MTC896 Gel ) compare placebo control . Subjects randomize 1 2 treatment group , 0.75 % ( w/w ) MTC896 Gel Placebo . Approximately 134 subject enrol yield 60 complete subject group . One group receive daily topical application 0.75 % ( w/w ) MTC896 Gel forehead 28 consecutive day , receive placebo identical regimen . Enrollment stagger allow monitoring safety tolerability . A lead cohort include approximately 20 subject ( 10 MTC896 Group 10 Placebo Group ) . Application additional subject initiate lead cohort complete study .</detailed_description>
	<criteria>1 . Are healthy male ; 2 . Are 18 65 year age ; 3 . Have selfperceived oily skin confirm clinical assessment ; 4 . Have average Sebumeter® reading ≥ 220 µg/cm2 forehead ; 5 . Have negative urine drug screen test result ; 6 . Have negative HIV hepatitis screen test result ; 7 . Agree use adequate contraceptive precaution ( ie , use condom ) conduct study ; 8 . Have body mass index ( BMI ) 19 34 kg/m2 ; 9 . Are free systemic dermatologic disorder , , opinion investigator , interfere study result increase risk adverse event ; 10 . Are willing abstain use facial treatment product personal care product ( moisturizer , sunscreen , hair spray , etc ) forehead study ; 11 . Are willing avoid sun exposure protect forehead hat/visor ; 12 . Are fluent English language ; 13 . Complete standard Medical Screening form well Medical Personal History form ; 14 . Read , understand , provide sign informed consent . 1 . Have visible skin disease application site , opinion investigator , interfere study evaluation ; 2 . Have history photosensitive reaction history cutaneous systemic lupus disorder frequently associate photosensitivity ; 3 . Are willing refrain use systemic/topical analgesic aspirin ( 81 mg daily aspirin allow discretion PI ) , Aleve , Motrin , Advil , Nuprin 24 hour prior study ( use acetaminophen permit ) ; 4 . Are use systemic/topical corticosteroid test area 3 week prior study , systemic/ antihistamine 24 hour prior study ; 5 . Are use topical retinoids , product contain benzoyl peroxide , salicylic acid , alphahydroxy acid 2 week prior study ; systemic retinoids within 3 month prior ; 6 . Are use medication , opinion investigator , interfere study evaluation ; 7 . Have seborrheic dermatitis and/or active atopic dermatitis/eczema around test site ; 8 . Have know allergy and/or hypersensitivity constituent present study product ; 9 . Have damage skin around test site , include sunburn , excessively deep tan , uneven skin tone , tattoo , scar , excessive hair , numerous freckle , disfiguration test site ; 10 . Have receive treatment type internal cancer within 5 year prior study enrollment ; 11 . Have history , currently treat skin cancer ; 12 . Are currently participate clinical testing ; and/or 13 . Have receive investigational treatment ( ) within 4 week prior study enrollment .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Oily Skin</keyword>
	<keyword>Sebum</keyword>
</DOC>